目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONS CONSIDERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.4.1 IMPACT OF AI/GENERATIVE AI

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ASSESSMENT
2.5 RESEARCH ASSUMPTIONS
2.6 STUDY LIMITATIONS
2.7 GROWTH RATE ASSUMPTIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 MEDICAL HUMIDIFIER MARKET OVERVIEW
4.2 ASIA PACIFIC MEDICAL HUMIDIFIER MARKET SHARE, BY APPLICATION AND COUNTRY
4.3 MEDICAL HUMIDIFIER MARKET, BY COUNTRY
4.4 MEDICAL HUMIDIFIER MARKET, REGIONAL MIX, 2024 VS. 2029
4.5 MEDICAL HUMIDIFIER MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising use of medical humidifiers in ventilation therapy
5.2.1.2 Increasing prevalence of respiratory diseases
5.2.1.3 Rising incidence of premature births and advances in neonatal care
5.2.1.4 Rapid growth in geriatric population
5.2.2 RESTRAINTS
5.2.2.1 Frequent replacement of disposable components, increasing operational costs
5.2.2.2 Low awareness of threat of respiratory diseases
5.2.3 OPPORTUNITIES
5.2.3.1 Post-pandemic demand for respiratory care
5.2.3.2 Government and non-government initiatives in respiratory health
5.2.3.3 Increasing investments in hospital infrastructure in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Risk of infections due to improper maintenance
5.2.4.2 High cost of advanced humidifiers to limit adoption
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.3.2 AVERAGE SELLING PRICE TREND, BY REGION
5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & DEVELOPMENT (R&D)
5.4.2 MANUFACTURING
5.4.3 DISTRIBUTION AND MARKETING & SALES
5.4.4 POST-SALES SERVICES
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
5.6 ECOSYSTEM ANALYSIS
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.2 REGULATORY FRAMEWORK
5.7.2.1 North America
5.7.2.1.1 US
5.7.2.1.2 Canada
5.7.2.2 Europe
5.7.2.3 Asia Pacific
5.7.2.3.1 China
5.7.2.3.2 Japan
5.7.2.3.3 India
5.7.2.4 Latin America
5.7.2.4.1 Brazil
5.8 PATENT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 IMPORT DATA FOR HS CODE 901920
5.9.2 EXPORT DATA FOR HS CODE 901920
5.10 KEY CONFERENCES & EVENTS, 2025-2026
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Heating technology
5.12.2 COMPLEMENTARY TECHNOLOGIES
5.12.2.1 Bubble diffusion technology
5.13 PORTER'S FIVE FORCES ANALYSIS
5.13.1 THREAT OF NEW ENTRANTS
5.13.2 THREAT OF SUBSTITUTES
5.13.3 BARGAINING POWER OF SUPPLIERS
5.13.4 BARGAINING POWER OF BUYERS
5.13.5 INTENSITY OF COMPETITIVE RIVALRY
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.14.2 BUYING CRITERIA
5.15 INVESTMENT & FUNDING SCENARIO
5.16 IMPACT OF AI/GENERATIVE AI ON MEDICAL HUMIDIFIER MARKET
5.16.1 INTRODUCTION
5.16.2 AI USE CASES
5.16.3 AI IN MEDICAL HUMIDIFIERS

6 MEDICAL HUMIDIFIER MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 HEATED HUMIDIFIERS
6.2.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET
6.3 HEAT & MOISTURE EXCHANGERS
6.3.1 RISING DEMAND FOR COST-EFFECTIVE AND DISPOSABLE HMES TO DRIVE MARKET
6.4 BUBBLE HUMIDIFIERS
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN HUMIDIFICATION SYSTEMS TO PROPEL MARKET GROWTH
6.5 HUMIDIFIER ACCESSORIES
6.5.1 INCREASED REPLACEMENT FREQUENCY OF ACCESSORIES TO FUEL DEMAND

7 MEDICAL HUMIDIFIER MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 INTENSIVE CARE UNITS
7.2.1 INCREASE IN ICU ADMISSIONS TO DRIVE MARKET GROWTH
7.3 NEONATAL CARE
7.3.1 RISING PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO DRIVE MARKET
7.4 RESPIRATORY THERAPY
7.4.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE DEMAND
7.5 OTHER APPLICATIONS

8 MEDICAL HUMIDIFIER MARKET, DISTRIBUTION CHANNEL
8.1 INTRODUCTION
8.2 HOSPITAL PHARMACIES
8.2.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS AND BULK PURCHASES OF MEDICAL HUMIDIFIERS TO DRIVE MARKET
8.3 RETAIL PHARMACIES
8.3.1 RISING DEMAND FOR HOME-BASED RESPIRATORY CARE SOLUTIONS TO DRIVE MARKET
8.4 ONLINE PHARMACIES
8.4.1 RISE IN E-COMMERCE ADOPTION AND DIGITAL TRANSFORMATION IN HEALTHCARE TO SUPPORT MARKET GROWTH

9 MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE
9.1 INTRODUCTION
9.2 ADULT PATIENTS
9.2.1 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE THE MARKET
9.3 NEONATAL PATIENTS
9.3.1 RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL MARKET GROWTH
9.4 PEDIATRIC PATIENTS
9.4.1 RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL GROWTH

10 MEDICAL HUMIDIFIER MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS & AMBULATORY SURGERY CENTERS
10.2.1 RISING NUMBER OF ICU ADMISSIONS AND PREFERENCE FOR AMBULATORY SURGERY TO DRIVE DEMAND
10.3 HOME CARE SETTINGS
10.3.1 RISING ELDERLY POPULATION TO DRIVE DEMAND FOR HOME-USE DEVICES
10.4 SPECIALTY CLINICS
10.4.1 INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISORDERS TO DRIVE MARKET
10.5 OTHER END USERS

11 MEDICAL HUMIDIFIER MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Rising premature births and advances in neonatal care to drive market
11.2.3 CANADA
11.2.3.1 Increasing prevalence of respiratory diseases to drive market
11.3 EUROPE
11.3.1 EUROPE: MACROECONOMIC OUTLOOK
11.3.2 GERMANY
11.3.2.1 Increasing public healthcare expenditure to foster market growth
11.3.3 UK
11.3.3.1 Increasing incidence of respiratory conditions such as COPD and asthma to drive market
11.3.4 FRANCE
11.3.4.1 High prevalence of COPD to surge demand
11.3.5 ITALY
11.3.5.1 Increasing geriatric population to support demand for humidifiers
11.3.6 SPAIN
11.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
11.4.2 CHINA
11.4.2.1 Growing elderly demographic to propel market
11.4.3 JAPAN
11.4.3.1 High prevalence of respiratory diseases to drive market growth
11.4.4 INDIA
11.4.4.1 Expanding healthcare infrastructure to drive demand
11.4.5 AUSTRALIA
11.4.5.1 High prevalence of COPD & asthma to drive market growth
11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 HIGH NEONATAL MORTALITY RATE TO DRIVE MARKET
11.5.2 LATIN AMERICA: MACROECONOMIC OUTLOOK
11.6 MIDDLE EAST & AFRICA
11.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS
11.6.2 MIDDLE EAST &AFRICA: MACROECONOMIC OUTLOOK
11.7 GCC COUNTRIES
11.7.1 SIGNIFICANT INVESTMENTS IN DEVELOPMENT AND EXPANSION OF HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
11.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK

12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
12.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
12.4 REVENUE ANALYSIS, 2021-2023
12.5 MARKET SHARE ANALYSIS, 2023
12.5.1 RANKING OF KEY MARKET PLAYERS
12.6 COMPANY SHARE ANALYSIS, BY PRODUCT
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.7.1 STARS
12.7.2 EMERGING LEADERS
12.7.3 PERVASIVE PLAYERS
12.7.4 PARTICIPANTS
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.7.5.1 Company footprint
12.7.5.2 Region footprint
12.7.5.3 Product footprint
12.7.5.4 Application footprint
12.7.5.5 End-user footprint
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.8.1 PROGRESSIVE COMPANIES
12.8.2 RESPONSIVE COMPANIES
12.8.3 DYNAMIC COMPANIES
12.8.4 STARTING BLOCKS
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.8.5.1 Detailed list of key startups/SMEs
12.8.5.2 Competitive benchmarking of key emerging players/startups
12.9 COMPANY VALUATION & FINANCIAL METRICS
12.9.1 FINANCIAL METRICS
12.9.2 COMPANY VALUATION
12.10 BRAND/PRODUCT COMPARISON
12.11 COMPETITIVE SCENARIO
12.11.1 PRODUCT LAUNCHES
12.11.2 DEALS
12.11.3 EXPANSIONS

13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 FISHER & PAYKEL HEALTHCARE LIMITED
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches
13.1.1.3.2 Expansions
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices made
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 RESMED INC.
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 MnM view
13.1.2.3.1 Key strengths
13.1.2.3.2 Strategic choices made
13.1.2.3.3 Weaknesses and competitive threats
13.1.3 DRAGERWERK AG & CO. KGAA
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 MnM view
13.1.3.3.1 Key strengths
13.1.3.3.2 Strategic choices made
13.1.3.3.3 Weaknesses and competitive threats
13.1.4 KONINKLIJKE PHILIPS N.V.
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.5 VINCENT MEDICAL HOLDINGS LIMITED
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Expansions
13.1.6 MEDLINE INDUSTRIES, LP.
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Deals
13.1.6.3.2 Expansions
13.1.7 HAMILTON MEDICAL
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Expansions
13.1.8 GALEMED CORPORATION
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches
13.1.9 EAKIN HEALTHCARE
13.1.9.1 Business overview
13.1.9.2 Products offered
13.2 OTHER PLAYERS
13.2.1 VADI MEDICAL TECHNOLOGY CO., LTD.
13.2.2 SHENYANG RMS MEDICAL TECH CO., LTD
13.2.3 FLEXICARE (GROUP) LIMITED
13.2.4 BESMED HEALTH BUSINESS CORP
13.2.5 LOWENSTEIN MEDICAL SE & CO. KG
13.2.6 INTERSURGICAL
13.2.7 PRECISION MEDICAL, INC.
13.2.8 DRIVE DEVILBISS INTERNATIONAL
13.2.9 NEOKRAFT MEDICAL PVT. LTD.
13.2.10 DYNAREX CORPORATION
13.2.11 HSI LLC.
13.2.12 TRUDELL MEDICAL LIMITED
13.2.13 GREAT GROUP MEDICAL CO., LTD.
13.2.14 FANEM
13.2.15 HEYER MEDICAL AG
13.2.16 BIOSYS

14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS